Evaluation of serum hepcidin concentrations in Parkinson’s disease patients

      Objective: Parkinson’s disease (PD) is characterized by the deposition of inclusion bodies (Lewy bodies) of α-synuclein in substantia nigra, which is ubiquitously expressed in the brain and mutations in this protein are presented in familial forms of AD. Dopamine as a neurotransmitter, and at the same time is a very good metal chelator and electron donor that define the conditions in vivo generation of toxic free radicals. It has a high propensity to coordinate with Cu2+ and Fe3+ and reduce metal primer Fenton generation of H2O2.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Parkinsonism & Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect